Vaccine: X Молекулярная медицина

Immunogenicity and safety of SARS-COV-2 recombinant protein subunit vaccine (INDOVAC) in west Sumatera Province adolescents: A phase 3, observer blind, randomized, active-controlled

Asrawati Nurdin, Bernie Endyarni Medise, Cahya Dewi Satria, Mita Puspita, Raveinal, Andani Eka Putra, Finny Fitry Yani, Fenty Anggrainy, Afriani, Linosefa, Rizanda Machmud, Dovy Djanas, Putri Awaliyah Deza, Vovinda Rujiana, Nur Aswad, Hartono Gunardi, Rini Sekartini, Nia Kurniati, Angga Wirahmadi, Madeline Ramdhani Jasin, Niken Wahyu Puspaningtyas, Afrilia Intan Pratiwi, Weda Kusuma, Braghmadita Widya Indraswari, Prambudi Rukmono, Dyah Perwitasari, Putu Aditya Wiguna, Komang Ayu Witarini, Ida Ayu Sri Kusuma Dewi, Rini Mulia Sari, Gianita Puspita Dewi, Jarir At Thobari
Elsevier · · DOI 10.1016/j.jvacx.2026.100896

Аннотация у издателя не опубликована — полный текст доступен по ссылке ниже.

Читать у издателя →